European Companies Search Engine
UK funding (£267,193): GENOMIC ANALYSIS OF AFRICAN OESOPHAGEAL SQUAMOUS CELL CARCINOMA Ukri9 Mar 2017 UK Research and Innovation, United Kingdom
Overview
Text
GENOMIC ANALYSIS OF AFRICAN OESOPHAGEAL SQUAMOUS CELL CARCINOMA
| Abstract | Oesophageal squamous cell carcinoma (OSCC) is a form of cancer of the oesophagus that is very common in many developing countries, with about 85% of cases occurring in these countries. There are no early symptoms and the patients report to hospital when the cancer is already at an advanced stage. Despite the high incidence in many parts of Africa, very little is known about the causes of the disease and the genetic risk if individuals. In this study we will do whole genome sequence analysis on patient DNA in order to identify the genetic changes and potential environmental carcinogens and mutagens that could play a role in the development of the disease. We will also explore the use of this information for personalised anticancer drug therapy based on patient specific gene defects |
| Category | Intramural |
| Reference | MC_PC_16097 |
| Status | Closed |
| Funded period start | 09/03/2017 |
| Funded period end | 30/06/2021 |
| Funded value | £267,193.00 |
| Source | https://gtr.ukri.org/projects?ref=MC_PC_16097 |
Participating Organisations
| University of Cape Town | |
| The Wellcome Trust Sanger Institute |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: University of Cape Town Retirement Fund Retirement Fund, Cape Town, South Africa.
The visualizations for "University of Cape Town - UK funding (£267,193): GENOMIC ANALYSIS OF AFRICAN OESOPHAGEAL SQUAMOUS CELL CARCINOMA"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
